Novo Nordisk Rejects Claim It Influences GLP-1 Market
By Aneeta Mathur-Ashton · April 29, 2026, 5:35 PM EDT
Pharmaceutical giant Novo Nordisk told a Texas federal judge that it does not control the GLP-1 market and has not attempted to crush its competition in a bid to dismiss an...
To view the full article, register now.